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A B S T R A C T 
The known Schiff base, 3-(2-aminophenylamino)-1-phenylbut-2-en-1-one (1), formed by 1:1 
condensation of o-phenylenediamine and benzoylacetylacetone reacts at its free amine site 
with salicylaldehyde and 5-tert-butylsalicylaldehyde in the presence of Ni(II) and Cu(II) 
acetates, or with 5-tert-butylsalicylaldehyde in the presence of Zn(II) acetate, to generate 1:1 
(M:L) diimine complexes (2) of the corresponding doubly deprotonated, unsymmetric, O2N2-
tetradentate ligands. In contrast, reaction of Zn(II) acetate with 1 and salicylaldehyde led to 
Schiff base exchange (with loss of benzoylacetylacetone) to yield symmetric [ZnL3] [where 
L3 is N,N'-o-phenylenebis(salicyliminato)]. Similarly, when Fe(II) chloride was substituted 
for metal acetate in the reaction of 1 with 5-tert-butyl-salicylaldehyde and the initial product 
crystallised in the presence of dabco (as base), a related Schiff base exchange reaction 
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occurred along with aerial oxidation of the Fe(II) to produce the neutral dinuclear 
[FeIII(L4)2(µ-O)] species [where L4 is N,N'-o-phenylenebis(5-tert-butylsalicyliminato)] in 
which Fe(III) centres are linked by an oxo group to produce two 5-coordinate Fe(III) centres; 
pairs of these (oxo-bridged) dinuclear complex units are further linked via elongated 
intermolecular Fe-Ophenolic contacts (Fe-O, 2.44 Å) to form an unusual tetranuclear 
supramolecular cluster.  This complex was also synthesised directly by the in situ reaction of 
5-tert-butyl-salicylaldehyde, o-phenylenediamine and Fe(II) chloride (2:1:1 mol ratio) in air. 
In an extension of these studies, the in situ reaction of the 1,3-aryl linked bis-β-diketone, 1,1-
(1,3-phenylene)-bis-butane-1,3-dione), o-phenylenediamine, salicylaldehyde and Ni(II) 
acetate in a 1:2:2:2 ratio yielded [Ni2L5], the dinuclear analogue of the unsymmetric 
mononuclear Ni(II) complex 2, in which each nickel centre has a square planar environment. 
Reaction of the above 1,3-phenylene linked bis-β-diketone precursor with o-
phenylenediamine in a 1:2 molar ratio yields 1,3-bis(4-methyl-3H-benzo[b][1,4]diazepin-2-
yl)benzene as its monohydrate (3·H2O) incorporating two 7-membered diaza heterocyclic 
rings; thus contrasting with the 'open' Schiff base structure observed for 1. X-ray structures of 
1, 3·H2O, [NiL1]·py, [NiL1]·EtOH, [NiL2], [CuL1]·py, [CuL1]·0.5CHCl3, [(FeL4)2(µ-
O)]2·1.5THF·0.4EtOH·0.6H2O and [NiL5]·0.25EtOH·0.125py are reported. 
____________________________________________________________________ 
 
1.  Introduction 
Symmetrical Schiff bases derived from 2:1 condensation of β-diketone or salicylaldehyde 
derivatives with a 1,2-diamine moiety represent, not only some of the earliest examples of 
tetradentate ligand types but also some of the most studied [1-4].  Indeed such species have 
been known since Alfred Werner's time. [1] Ligands of this type typically lose two protons 
and coordinate in a square-planar manner to form neutral metal complexes with a number of 
divalent metal ions. Individual complexes have been investigated for a number of 
applications, including as oxygen carriers [5], non-linear optical materials [6], as catalysts 
(and especially asymmetric catalysts) [2,7], in inorganic biochemical roles [8] and as 
components of metallosupramolecular systems [2,9]. In contrast to symmetrical Schiff base 
systems, unsymmetric systems have received significantly less attention, in part reflecting 
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that their syntheses are usually [6,10,11] (but not always) [12] somewhat less facile than for 
related symmetrical systems. 
 Previous studies [11,13,14] have shown that o-phenylenediamine undergoes 
1:1 Schiff base condensation with individual β-diketones; for example, reaction with 
benzoylacetylacetone yields 3-(2-aminophenylamino)-1-phenylbut-2-en-1-one (1) that 
incorporates a free amine site [11,13]. As an extension of these prior studies, we now report 
the metal template syntheses of new Ni(II), Cu(II) and Zn(II) complexes of type 2 (see Fig. 
1). These incorporate the deprotonated forms of the unsymmetric ligands, H2L1 (R = H) and 
H2L2 (R = t-Bu), derived respectively from 1:1 condensation of 1 with salicylaldehyde or 5-
tert-butylsalicylaldehyde. Related symmetric Zn(II) and Fe(III) complexes of type 3 
incorporating respectively N,N'-o-phenylenebis(salicyliminato) (L3) and N,N'-o-
phenylenebis(5-tert-butylsalicyliminato) (L4) generated by Schiff base exchange reactions are 
also reported. The formation of a related dinuclear Ni(II) Schiff base complex([Ni2L5]) 
incorporating the deprotonated form of the difunctional ligand 4  is described, with the latter 
derived from the condensation of 1 with the 1,3-phenylene-linked bis-β-diketone derivative, 
1,1'-(1,4-phenylene)bisbutane-1,3-dione.  
 
 
Fig. 1.  Synthesis of the 1:1 Schiff base intermediate 3-(2-aminophenylamino)- 1-phenylbut-
2-en-1-one, 1, followed by in situ reaction with salicylaldehyde or 5-tert-butylsalicylaldehyde 
in the presence of Ni(II), Cu(II) or Zn(II) acetate to produce complexes of type 2, [ML1] (M = 
Ni, Cu) or [CuL2], that incorporate the doubly deprotonated forms of the unsymmetric 
ligands H2L1 (R = H) and H2L2 (R = t-Bu). 
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2.  Experimental 
2.1. Materials and instrumentation 
All reagent and solvents were obtained from commercial sources and used without 
further purification. 1H NMR spectra were recorded on a Bruker Avance DPX200 
spectrometer with (CH3)4Si as the internal reference. Mass spectra (ESI-MS) were obtained 
on a Finnigan LCQ-8 spectrometer with the sample dissolved in methanol. UV-Vis spectra of 
the Ni(II) complexes were recorded on a Cary 1E spectrophotometer; in each case the d-d 
transition assigned to square planar coordination (due to the 1A1g to 1B1g transition) was partly 
obscured by the tail of an intense MLCT transition that extended from the UV region into the 
visible. Unless otherwise stated, all products were dried in air over silica gel before 
microanalysis. 
 
2.2.  Ligand and complex synthesis  
3-(2-Aminophenylamino)-1-phenylbut-2-en-1-one (1):  This was prepared by reaction 
of o-phenylenediamine with benzoylacetone using a similar procedure to that reported 
N
NH O HN
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previously [13]. Yield 75%. 1H NMR (δ, ppm /CDCl3): 12.47 (H, br), 7.92 (2H, m), 7.44 
(3H, m), 7.06 (2H, m), 6.76 (2H, m), 5.93 (1H, s), 3.87 (2H, br), 1.99 (3H, s). MS(ESI+): 
253.0 (M+H+). An X-ray diffraction study on a colourless single crystal of this product 
confirmed its expected structure. 
 
2.2.1.  General procedure for the synthesis of Ni(II), Cu(II) and Zn(II) complexes of type 2 
incorporating unsymmetric L1 and L2 
The procedure is a modified version of that previously reported for [NiL1] [11] (which 
was also synthesised in the present study as its ethanol solvate). Intermediate 1 (1 mmol) and 
salicylaldehyde or 5-tert-butyl-salicylaldehyde (1 mmol) (to produce H2L1 and H2L2 
respectively) were dissolved in hot ethanol (15 mL). The mixture was heated under reflux for 
1 h, and then 1 mmol of Ni(II) acetate tetrahydrate, Cu(II) acetate monohydrate or Zn(II) 
acetate dihydrate in ethanol (5 mL) was added dropwise to the warm solution. The reaction 
mixture was heated at reflux for 2 h and then left overnight at room temperature. In each case 
the precipitate that formed was removed by filtration and recrystallised from ethanol. 
 
[NiL1]·EtOH and [NiL1]·py   
[NiL1]·EtOH: yield 78%, dark red-brown crystals. 1H NMR (δ, ppm/CDCl3): 8.18 
(1H, s), 7.87 (2H, d), 7.53 (1H, d), 7.35 (6H, m), 7.05 (3H, m), 6.64 (1H, t), 6.02 (1H, s), 2.52 
(3H, s). UV-vis (pyridine): λ ~570 (sh) nm. Calc. for C25H24NiN2O3: C, 65.50; H, 5.24; N, 
6.11. Found: C, 65.57; H, 4.71; N, 6.51%. Crystals suitable for X-ray analysis were obtained 
by slow evaporation of an ethanol solution of the above product and one of these was used 
for an X-ray structure determination. [NiL1]·py: A portion of the above product was 
recrystallised from pyridine (py) to yield brown crystals of [NiL1]·py; a crystal from this 
batch was used directly for a structure determination. 
 
[NiL2]·0.33H2O   
Yield 85%, dark red-brown crystals. 1H NMR (δ, ppm/CDCl3) 8.17 (1H, s), 7.86 (2H, 
s), 7.64 (1H, d), 7.39 (3H, m), 7.36 (2H, m), 7.22 (1H, m), 7.04 (3H, m), 6.02 (1H, s), 2.52 
(3H, s), 1.30 (9H, s). UV-vis (pyridine), λ ~570 (sh) nm. Calc. for C27H26.66NiN2O2.33: C, 
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68.25; H, 5.66; N, 5.90%. Found: C, 68.24; H, 5.67; N, 5.93%. Crystals of [Ni(L2)] suitable 
for X-ray analysis were obtained by slow evaporation of an ethanol solution of the above 
product. 
 
[CuL1]·0.5CHCl3  
Yield 89%, dark green crystals. MS(ESI+): 418.20 (M+H)+. Calc. for C23H18CuN2O2: C, 
66.10; H, 4.34; N, 6.70. Found: C, 65.85; H, 4.35; N, 6.78%. Crystals of composition of 
[CuL1]·0.5CHCl3 suitable for X-ray crystal analysis were obtained on slow evaporation of 
chloroform solution. They were used directly for a structure determination. On prolonged 
drying in air, this product lost chloroform to give the non-solvated product. Calc. for 
C23H18CuN2O2: C, 66.10; H, 4.34; N, 6.70. Found: C, 65.85; H, 4.35; N, 6.78%. 
 
[CuL1]·py   
Green crystals of composition [CuL1]·py, suitable for X-ray crystal analysis, were obtained 
on slow evaporation of a pyridine solution of the above  product. Calc. for C28H23CuN3O2: C, 
67.66; H, 4.66; N, 8.45. Found: C, 67.62; H, 4.65; N, 8.55%. 
 
[CuL2]·0.5H2O   
Yield 82%, dark green crystals. MS(ESI+): 474.1 (M+H)+. Calc. for C27H27CuN2O2.5: 
C, 67.13; H, 5.63; N, 5.80. Found: C, 67.17; H, 5.37; N, 5.70%.  
 
[ZnL2]·1.5H2O   
Yield 53%, yellow crystals. 1H NMR (δ, ppm/CDCl3) 8.31 (1H, s), 7.72 (2H, d), 7.29 
(3H, m), 7.11 (2H, m), 6.90 (2H, m), 5.39 (1H, s), 2.16 (3H, s), 1.24 (9H, s).  
MS(ESI+): 475.27(M+H)+. Calc. for C27H29N2O3.5Zn: C, 64.48; H, 5.81; N, 5.57. Found: C, 
64.42; H, 5.97; N, 5.50%.  
 
[Ni2L5]·0.25EtOH·0.125py   
1,1´-(1,3-Phenylene)-bis-butane-1,3-dione [15], (1 mmol), o-phenylenediamine (2 
mmol) and salicylaldehyde (2 mmol) were dissolved in hot ethanol (25 mL). The reaction 
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mixture was refluxed for 1 h and then Ni(II) acetate tetrahydrate (2 mmol) in ethanol (5 mL) 
was added dropwise to the warm solution. The reaction mixture was refluxed for a further 2 
h, and then left overnight at room temperature. The product formed as red-brown crystals. 
Yield 80%,. UV-vis (pyridine), λ ~570 (sh) nm. 1H NMR (δ, ppm/CDCl3) 8.28 (1H, s), 8.20 
(2H, s), 7.99 (2H, m), 7.66 (2H, m), 7.36 (5H, m), 7.15 (4H, m), 6.98 (4H, m), 6.66 (2H, m), 
6.12 (2H, s), 2.56 (6H, s). MS(ESI+): 768.87 (M+Na)+. Slow evaporation of a pyridine 
solution of this product yielded crystals suitable for X-ray analysis and a crystal from this 
batch was used directly for the structure determination.  
 
 2.2.2. Schiff base exchange reactions  
[ZnL3]·H2O   
This complex was obtained from Zn(II) acetate using the general procedure outlined 
above. The procedure led to Schiff base condensation coupled with imine exchange (with loss 
of benzoylacetylacetone) to yield the symmetric mononuclear complex [ZnL3]·H2O (L3 is the 
doubly deprotonated form of N,N'-o-phenylenebis(salicylimine). Yield 48%, yellow crystals. 
1H NMR (δ, ppm/DMSO-d6): 9.04 (2H, s), 7.93 (2H, m), 7.43 (4H, m), 7.24 (2H, t), 6.73 
(2H, d), 6.54 (2H, t). MS(ESI+): 379.20 (M+H)+. Calc. for C20H16N2O3Zn: C, 60.40; H, 4.05; 
N, 7.04. Found: C, 60.92; H, 4.20; N, 7.05%. 
 
 
[(FeL4)2(µ-O)]2·3.5H2O (where L4 is the doubly deprotonated form of N,N'-o-phenylenebis(5-
tert-butylsalicylimine) 
This complex was synthesised by the general procedure outlined in Section 2.2.1 
employing intermediate 1, 5-tert-butyl-salicylaldehyde and an ethanol/chloroform (1:1) 
solvent mixture but with Fe(II) chloride (1 mmol) substituted for the metal acetate. Once 
again Schiff base condensation coupled with imine exchange (with loss of 
benzoylacetylacetone) was observed to occur. The initial non-crystalline product obtained 
was dissolved in a 1:1 mixture of tetrahydrofuran and ethanol containing one equivalent of 
the difunctional base dabco. Dark red crystals formed on slow evaporation of this solution 
over several days. Yield, 70 %. These were removed from solution and since they tended to 
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lose solvent on standing, a crystal from this batch was used directly for an X-ray structure 
determination without further drying.  
This complex was also synthesised by the more direct in situ reaction of 5-tert-butyl-
salicylaldehyde, o-phenylenediamine and iron(II) chloride (2:1:1 mol ratio) in ethanol (thus 
circumventing the Schiff base exchange step in the above synthesis).  
o-Phenylenediamine (1 mmol) and 5-tert-butyl-salicylaldehyde (2 mmol) were dissolved 
in hot ethanol (15 mL). The mixture was heated under reflux for 1 h, then iron(II) chloride 
tetrahydrate (1 mmol) in ethanol (5 mL) was added dropwise to the warm solution. The 
reaction mixture was heated at reflux for 2 h and then left overnight at room temperature. The 
dark brown precipitate that formed was then collected, dissolved in a 1:1 mixture of 
tetrahydrofuran and ethanol containing one equivalent of dabco as base (note: attempts to 
isolate the same product without the addition of dabco failed to produce crystalline 
materials). The resulting dark brown solution was allowed to stand for several days over 
which time dark red crystals of product formed.  These were isolated and allowed to dry in air 
over several days. Yield 0.233 g (65 %). UV-vis (Nujol): λ 415 nm. MS(ESI+): 1003.3 
[(FeL4)2O+Na]+. Calc. for C112H120Fe4N8O10·3.5H2O: C, 66.44; H, 6.32; N, 5.53. Found: C, 
66.35; H, 6.19; N, 5.56 %.  
 
 
2.3. Crystallography 
2.3.1. Data collection and structure solution 
X-ray structural data were collected on either a Bruker-Nonius APEX2-X8-FR591 
diffractometer employing graphite-monochromated Mo-Kα radiation generated from a 
rotating anode (0.71073 Å) with ω and ψ scans [16] or with ω scans using a Bruker SMART 
1000 diffractometer employing graphite-monochromated Mo-Kα radiation generated from a 
sealed tube (0.71073 Å). Data were collected at 150 K to approximately 56° 2θ. Data 
integration and reduction were undertaken with SAINT and XPREP [18] and subsequent 
computations were carried out using the WinGX-32 graphical user interface [19]. The 
structures were solved by direct methods using SIR97 [20]. Multi-scan empirical absorption 
corrections were applied to the data set using the program SADABS [21]. Data were refined 
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and extended with SHELXL-97 [22]. In general, non-hydrogen atoms with occupancies 
greater than or equal to 0.5 were refined anisotropically. Carbon and alcohol O-bound 
hydrogen atoms were included in idealised positions and refined using a riding model. Water 
hydrogen atoms were first located in the difference Fourier map before refinement with bond 
length and angle restraints as required to facilitate realistic modelling where they could not be 
located they were not modelled. X-ray data is summarised in Table 1 and specific refinement 
details (where required) are given below. 
 
2.3.2. Specific refinement details  
[NiL1]·EtOH   
Each of the ethanol solvent molecules are disordered and modelled over two positions. 
 
[(FeL4)2(µ-O)]2·1.5THF·0.4EtOH·0.6H2O 
 One of the THF molecules and the water molecules are disordered and each was modelled 
over two positions. The water hydrogens could not be located in the difference Fourier map 
and were not modelled. A number of bond length and angle restraints were required in the 
modelling of the disordered THF and the ethanol molecule. 
 
[Ni2L5]·0.25EtOH·0.125py 
 The ethanol and pyridine solvate molecules are disordered across a special position and a 
number of bond length and angle restraints were required to facilitate realistic modelling. 
 
4.  Results and Discussion  
Reaction of o-phenylenediamine and benzoylacetone in refluxing ethanol yielded the 1:1 
Schiff base condensation product 1 whose X-ray structure (Fig. 2) confirmed the previously 
assigned 'open' single imine structure [11,13] (rather than a 7-membered diaza ring structure 
of the type obtained previously from the 1:1 condensation of acetylacetone and 
ethylenediamine) [23]. Reaction of 1 with salicylaldehyde or 5-tert-butyl-salicylaldehyde in 
situ in the presence of Ni(II), Cu(II), or Zn(II) acetate resulted in metal template syntheses of 
the corresponding asymmetric Schiff base complexes of type 2: [NiL1]·py, [NiL1]·EtOH, 
[NiL2]·0.33H2O, [CuL1]·0.5CHCl3, [CuL1]·py, [CuL2]·0.5H2O and [ZnL2]·1.5H2O.   
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Fig. 2.  X-ray structure of the Schiff base intermediate, 3-(2-aminophenylamino)-1-
phenylbut-2-en-1-one (1), formed by 1:1 condensation of o-phenylenediamine and 
benzoylacetone, shown with 50 % probability ellipsoids. The dashed line indicates a 
hydrogen bond 
 
The X-ray structures of [NiL1]·py and [NiL1]·EtOH (Fig. 3a and b) are similar and 
confirm that the Ni(II) ion has a square planar coordination geometry in each case with the 
benzene ring from the o-phenylenediamine moiety rotated between 14 and 18 degrees with 
respect to the coordination plane in the respective structures. In both structures, two adjacent 
molecules pack closely together in a dimeric arrangement (Fig. 3b). There is a moderately 
close contact between the conjugated γ-carbon and the adjacent Ni(II) centres of 3.3 Å in the 
case of [NiL1]·py and 3.2 Å in [NiL1]·EtOH, which may assist with stabilisation of the close 
(dimeric) packing arrangement. Although such a contact does not seem to have been 
highlighted in the past, a search of the CSD revealed a number of other low-spin Ni(II), 
nominally square planar structures, that also show related Ni-pi system contacts [24]. These 
metal-pi contacts are reminiscent of those observed previously in a number of Cu(II) complex 
species [25].  
In [NiL1]·py there are also a number of weak pi-pi interactions between adjacent 
dimers and pyridine solvate molecules leading to an overall three dimensional network 
arrangement. In [NiL1]·EtOH the disordered solvent is hydrogen bonded to the coordinated 
oxygens and weak pi-pi interactions occur between dimers, resulting in a two-dimensional 
array that extends throughout the lattice. 
The crystal structure of [NiL2] (Fig. 4) shows that the metal is again square planar 
being bound to the O2N2 donor set of the doubly deprotonated form of H2L2; adjacent 
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molecules again pack closely to yield a dimeric arrangement. However, in contrast to the 
structures just discussed, there are no Ni-C distances of less than 3.5 Å (attributable to the 
steric influence of the bulky tert-butyl group); while there is a number of offset face-to-face 
pi-pi interactions present. Neighbouring dimers stack in a herringbone-like motif through edge-
to-face pi-pi interactions. 
 
Fig. 3. (a) X-ray structure of the [NiL1]·py with 50 % probability ellipsoids and (b) schematic 
representation of the dimeric close packing in [NiL1]·EtOH. Both complexes have similar 
square planar coordination geometries and dimeric packing arrangements. Dashed lines 
indicate intermolecular contacts between nickel centres and the pi-systems of adjacent bound 
L1 ligands; solvate molecules not shown.  
 
Fig. 4. X-ray structure of [NiL2] shown with 50 % probability ellipsoids. 
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In a similar fashion to the nickel complexes just discussed, the crystal structures of 
[CuL1]·py and [CuL1]·0.5CHCl3 reveal that the Cu(II) centres adopt square planar geometries 
(Fig 5). The crystal packing in [CuL1]·0.5CHCl3 is quite similar to that occurring for 
[NiL1]·py, with adjacent molecules forming dimeric species via Cu-pi interactions (3.1 Å) that 
appear similar to those described previously by us and others [25]. If these weak interactions 
are included as part of the coordination sphere then the overall coordination geometry can be 
considered as pseudo-five coordinate; the chloroform solvate molecule is hydrogen bonded to  
adjacent coordinated oxygens. Neighbouring dimers again interact via a series of weak pi-pi 
interaction to form an infinite three-dimensional arrangement. This contrasts slightly with the 
packing in [CuL1]·py in which the copper centres interact with o-phenylenediamine rings, 
indicated by Cu-C distances of 3.0–3.3 Å, forming infinite columnar arrays. These pi-stack 
further with adjacent columns and pyridine solvent molecules to yield an infinite three-
dimensional lattice. 
 
 
Fig. 5.  X-ray structures of (a) [CuL1]·py and (b) [CuL1]·0.5CHCl3 with 50 % probability 
ellipsoids; the pyridine solvate is not shown. 
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Unexpectedly, attempts to obtain mononuclear complexes of types [ZnL1] and [FeL2] 
using a similar procedure to that illustrated in Fig. 1, resulted instead in Schiff base exchange 
to yield the known [26] symmetric Schiff base complex [ZnL3] [where L3 is N,N'-o-
phenylenebis(salicylimineato)] (see Fig. 6) and the new Fe(III) species 
[(FeL4)2O]·1.5THF·0.4EtOH·0.6H2O [where L4 is N,N'-o-phenylenebis(5-tert-
salicylimineato)], the crystal structure of this iron complex was determined (see below). In 
these products the benzoylacetonimine moiety in the precursor 1 has been replaced by a 
salicylaldiminato or 5-tert-butylsalicyliminato group, undoubtedly reflecting the inherent 
solution lability of the imine functions present in 1 [27], with the exchange reaction 
representing an example of  "dynamic covalent chemistry",[28] perhaps driven by the 
formation of more thermodynamically stable symmetrical Schiff base products. Alternatively, 
the relative solubilities of the symmetrical versus the non-symmetrical products under the 
conditions employed could also be important in determining which of these products is 
isolated. 
 
 
Fig. 6.  Schiff base exchange reaction to form [ZnL3]. 
 
Crystals of the oxo-bridged species, [(FeL4)2O]·1.5THF·0.4EtOH·0.6H2O, suitable 
for X-ray diffraction were obtained on slow evaporation of a ethanol/chloroform solution of 
the initial isolated complex in the presence of added dabco as base. In forming this iron 
complex clearly the Fe(II) employed initially is aerially oxidised to Fe(III) during the course 
of the reaction which was carried out in air; other examples of such Fe(II)/Fe(III) oxidation in 
air have been documented [29]. This complex was also synthesised directly by the in situ 
N O
N O
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O OH
NH O
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1
+
Zn(II) +
[ZnL3]
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reaction of 5-tert-butyl-salicylaldehyde, o-phenylenediamine and Fe(II) chloride (2:1:1 mol 
ratio) in ethanol in air. 
Other related oxo bridged Fe(III) species incorporating Schiff base ligands derived 
from salicylaldehyde or its substituted derivatives have been reported [30,31]. The X-ray 
structure of the present complex (Fig. 7) shows that the iron centres in each [FeIIIL4]+ unit are 
bridged by an oxo bridge to form dinuclear [(FeL4)2O] units; pairs of these are then further 
intermolecularly linked via phenoxide oxygen to Fe(III) contacts (Fe-Ophenolic distances of 
2.44 Å) to form an unusual supramolecular [(FeL4)2O]2 tetranuclear cluster. The Fe-Ooxo-Fe 
angle is 153.6°, compared to 176.5° in the related complex, [{Fe(3,5-t-BuSalphen)}2(µ-O)] 
(where 3,5-t-BuSalphen is the corresponding ligand incorporating tert-butyl in both the 3- 
and 5-positions of its salicyl rings) [31]. Other aspects of the two structures are also quite 
similar, including the displacement of the five-coordinate iron centres from their respective 
mean basal planes (0.56 Å in the present structure compared to 0.54 Å and 0.55 Å in 
[{Fe(3,5-t-BuSalphen)}2(µ-O)]). However, the present structure differs by the presence of the 
bridging phenolic oxygens. Each of the resulting tetranuclear clusters interacts further with 
two neighbouring molecules via pi-pi interactions (indicated by carbon-carbon distances of 
3.2-3.4 Å); this results in the formation of an infinite one-dimensional polymer that 
propagates along the crystallographic b-axis. 
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Fig. 7.  X-ray structure of the tetrameric complex, [(FeL4)2(µ-O)]2·1.5THF·0.4EtOH·0.6H2O; 
hydrogen atoms and the lattice solvate molecules are not shown. 
  
In an extension of the above investigation (that also extends our past studies involving 
difunctional β-diketone ligands) [33] we have probed the use of the 1,3-phenylene-linked, 
bis-β-diketone derivative, 1,1-(1,3-phenylene)-bis-butane-1,3-dione [22], in place of 
benzoylacetylacetone, for undertaking related studies to those just described. In an initial 
attempt to obtain a phenylene-bridged bis-Schiff base analogue of 1 (see Fig. 1) incorporating 
terminal anilino groups by 1:2 reaction of the above bis-β-diketone derivative with o-
phenylenediamine in hot ethanol resulted instead in the formation of 5, 1,3-bis(4-(methyl)-
3H-benzo[b][1,4]diazepin-2-yl)benzene, as colourless crystals. 
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 The X-ray stucture of this product (Fig. 8), which crystallises as its monohydrate,  
confirmed that two partially conjugated, 7-membered, diaza-heterocyclic rings had been 
generated. This arrangement thus contrasts markedly with that obtained (Fig. 2) for the 
mono-Schiff base 1 discussed earlier, formed by 1:1 condensation of o-phenylenediamine and 
benzoylacetone (see Fig. 1). 
 
Fig. 8. X-ray structure of 3·H2O with 50 % probability ellipsoids; the water solvate is not 
shown. 
 
 The solvent water molecules in the crystal lattice of 3·H2O are involved in hydrogen 
bonding interactions with the 'outermost' nitrogen atoms of the 7-membered rings 
(O(1W)H·· ·  N(1) 1.99(4) Å) forming an undulating hydrogen bonded polymeric chain that 
extends along the crystallographic a-axis (Fig. 9).  
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Fig. 9. Part of the infinite hydrogen bonded chain in the X-ray structure of 3·H2O. 
 
 Despite the above result, it was found that an in situ (presumably template) reaction in 
which an ethanol solution of Ni(II) acetate was heated with 1,1-(1,3-phenylene)-bis-butane-
1,3-dione), o-phenylenediamine and salicylaldehyde in a 1:2.2 ratio resulted in isolation of 
the target dinuclear Schiff base nickel complex of type [Ni2L5] (6) whose X-ray structure 
(Fig. 10) indicated an overall composition of [Ni2L5] ·0.25EtOH·0.125py.  
 
N
N O N
NO O
O
Ni Ni
6; [Ni2(L4)]
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Fig. 10. The X-ray structure of {[Ni2L5]·0.25EtOH·0.125py shown with 50 % probability 
ellipsoids (top) and a schematic representation of the supramolecular interactions between 
adjacent molecules illustrating the Ni-O contacts (3.19 Å), the corresponding Ni-Ni distance 
is 3.38 Å; solvate molecules are not shown. 
 
 The two Ni(II) centres adopt, in a similar fashion to [NiL1], a low-spin square planar 
coordination geometry. The entire molecule is close to planar with only small deviations from 
planarity occurring for the methyl groups and o-phenylenediamine rings. Presumably 
reflecting steric effects, the coordinating moieties are arranged in a syn fashion so that the 
"salicylimine" aryl rings have maximum separation and lie closest to the 4 and 6 positions on 
the central 1,3-subsituted phenylene (rather than on the opposite side). This configuration is 
further stabilised by weak Hphenylene-O interactions. Interestingly, the syn arrangement 
contrasts with that adopted by the precursor bis-β-diketone ligand upon coordination, but 
parallels the arrangement adopted by the corresponding free ligand in the solid state [22]. 
 As observed in each of the structures reported above, the crystal packing is again 
dominated by pi-pi stacking. Adjacent molecules once more form a dimeric arrangement with 
close Ni-O contacts (3.19 Å). Neighbouring dimers undergo further offset face-to-face pi-pi 
interactions to form one-dimensional chains. Each of these chains then interact with others to 
yield a herringbone type motif through edge-to-face pi-pi stacking, leading to the formation of 
infinite sheet-like two-dimensional layers. The disordered solvent molecules are located 
between the layers. 
 
4.  Conclusions 
The results presented in this study are noteworthy on at least three counts. First, the 
known range of unsymmetrical tetradentate ligand complexes of Ni(II), Cu(II) and Zn(II) of 
type 2 has been extended and, in addition, two new Schiff base exchange reactions that yield 
corresponding doubly deprotonated symmetrical ligands complexes are reported. Secondly, 
the product of one of the exchange reactions has an unprecedented (as far as we are aware) 
supramolecular tetranuclear Fe(III) cluster structure incorporating both oxo bridges and 
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longer phenoxo-bridges between iron centres. Finally, [Ni2L5]·0.25EtOH·0.125py represents 
the first example of the new category of dinuclear complexes corresponding to the 
mononuclear (unsymmetric) Schiff base analogues of type 2. Further studies on systems of 
this latter type are planned.  
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[NiL1]·py, [NiL1]·EtOH, [NiL2], [CuL1]·py, [CuL1]·0.5CHCl3, [(FeL4)2(µ-
O)]2·1.5THF·0.4EtOH·0.6H2O and [NiL5]·0.25EtOH·0.125py. These data can be obtained 
free of charge via https://www.ccdc.cam.ac.uk/services/structure_deposit or from The 
Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: 
+44 1223 336 033, or e-mail: deposit@ccdc.cam.ac.uk. 
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Table 1 Crystal and structure refinement data 
Compound 1 [Ni(L1)]·py [Ni(L1)]·EtOH [Ni(L2)] [Cu(L1)]·py  [Cu(L1)]·0.5CHCl3             [Fe(L4)2(µ2-O)]2·1.5THF 
·0.4EtOH·0.6H2O 
 3·H2O [Ni2(L5)]·0.25EtOH 
·0.125py 
Formula of 
refinement model 
C16H16N2O C28H23N3NiO2 C25H24N2NiO3 C27H26N2NiO2 C28H23CuN3O2 C47H37Cl3Cu2N4O4  C62.80H75.60Fe3N4O7.50 C26H24N4O C41.625H32.625N4.125Ni2O4.25 
Molecular weight 252.31 492.20 1501.01 469.21 497.03 955.24  1118.17 408.49 776.01 
Crystal system Monoclinic Orthorhombic Monoclinic Monoclinic Monoclinic Monoclinic  Triclinic Orthorhombic Monoclinic 
Space group C2/c(#15) Pbca(#61) Cc(#9) P21/c(#14) P21/n(#14) P21/n(#14)  P1(#2) Pbcn(#60) P21/c(#14) 
a/ Å 15.5020(10) 16.209(2) 20.063(3) 12.4950(10) 13.200(3) 18.425(9)  12.083(5) 13.452(3) 11.6715(6) 
b/ Å 16.3660(10) 11.9420(15) 19.879(3) 16.2690(13) 9.639(2) 10.912(5)  14.335(6) 16.994(3) 22.0514(12) 
c/ Å 11.6720(7) 23.643(3) 22.246(3) 11.7310(10) 17.734(4) 22.707(14)  18.401(8) 9.221(2) 13.4293(7) 
α/°        72.461(8)   
β/° 111.136(3)  102.714(2) 113.7480(10) 93.023(3) 113.821(6)  86.676(9)  100.232(2) 
γ/°        82.305(7)   
V/ Å3 2762.0(3) 4576.5(10) 8655(2) 2182.8(3) 508.5(3) 4176(4)  3011(2) 2108.0(7) 3401.4(3) 
Dc/ g cm–1 1.214 1.429 1.410 1.428 1.465 1.519  1.233 1.287 1.515 
Z 8 8 16 4 4 4  2 4 4 
Crystal size/ mm 0.30 × 0.25 × 0.10 0.40 × 0.35 × 0.30 0.40 × 0.35 × 0.32 0.40 × 0.35 × 0.30 0.40 × 0.30 × 0.25 0.30× 0.20 × 0.05  0.40× 0.30 × 0.05 0.20× 0.10 × 0.05 03 × 0.2 × 0.05 
Crystal colour colourless brown brown brown green green  red colourless brown 
Crystal habit plate block block block prism plate  plate plate plate 
Temperature/ K 150(2) 150(2) 150(2) 150(2) 150(2) 150(2)  150(2) 150(2) 150(2) 
λ(MoKα)/ Å 0.71073 0.71073 0.71073 0.71073 0.71073 0.71073  0.71073 0.71073 0.71073 
µ(MoKα)/ mm–1 0.077 0.879 0.926 0.916 1.001 1.261  0.536 0.081 1.159 
T(SADABS)min,max 0.5140, 0.7461 0.6581, 0.7457 0.6323, 0.7457 0.6232, 0.7457 0.6471, 0.7457 0.5191, 0.7457  0.6587, 0.7457 0.6246, 0.7457 0.6454, 0.7457 
2θmax/° 60.88 56.64 56.64 56.62 56.74 52.74  54.26 56.50 56.70 
hkl range -22 17, -23 20, -16 16 -20 21, -15 15, -31 31 -26 26, -26 25, -29 29 -16 16, -21 21, -15 15 -17 17, -12 12, -23 23 -21 23, -13 13, -27 28  -15 15, -18 18, -23 23 -17 17, -22 22, -12 12 -15 15, -28 29, -17 17 
N 20528 43098 42827 21636 21684 29543  27429 12699 67496 
Nind (Rmerge) 4183 (0.0584) 5638 (0.0673) 20032 (0.0339) 5288 (0.0201) 5445 (0.0500) 8489 (0.0948)  13058 (0.0648) 2581 (0.1295) 8355 (0.0431) 
Nobs (I > 2σ(I)) 3362 3895 17227 4870 3824 5568  6933 947 6914 
Nvar 183 308 1150 293 308 543  722 146 481 
R1 a (F) (I > 2σ(I)) 0.0438 0.0379  0.0415 0.0290  0.0391 0.0982  0.0634 0.0689 0.0711 
wR2a (F2) (all) 0.1318 0.0854 0.1001 0.0827 0.0975 0.2634  0.2029 0.1630 0.1572 
Aa, Ba 0.0699, 1.2169 0.0354, 2.1618 0.0536, 2.1420 0.0488, 1.1140 0.0490,0.4488 0.0677, 84.4600  0.1099, 0.0000 0.0589, 0.0687 0.0000, 21.23520 
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GoF 1.032 0.990 1.013 1.004 1.010 1.049  0.969 0.980 1.243 
∆ρmin,max /e– Å–3 -0.291, 0.450 -0.258, 0.536 -0.361, 1.620 -0.248, 0.504 -0.447, 0.462 -1.270, 1.819  -0.935, 0.829 -0.364, 0.258 -0.888, 1.442 
 
a
 R1 = Σ||F
o
| - |F
c
||/Σ|F
o
| for F
o
 > 2σ(F
o
) and wR2 = (Σw(F
o
2
 - F
c
2)2/Σ(wF
c
2)2)1/2 where w=1/[σ2(F
o
2)+(AP)2+BP], P=(F
o
2
+2F
c
2)/3 and A and B are listed in the crystal data su
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Mono- and dinucleating Ni(II), Cu(II), Zn(II) and Fe(III) complexes of 
symmetric and unsymmetric Schiff bases incorporating salicylimine 
functions- synthetic and structural studies   
 
Qinghua Meng, Jack K. Clegg, Katrina A. Jolliffe,  Leonard F. Lindoy, Gang Wei  
 
Both unsymmetric and symmetrc Schiff base complexes, the latter formed by imine 
exchange,  are reported; included in the products are an unusual oxo-bridged Fe(III) 
tetranuclear cluster and a new dinuclear Ni(II) species.  
 
 
